Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 216970, 9 pages
http://dx.doi.org/10.1155/2012/216970
Research Article

An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study

1Department of Medicine, Srinivasa Diabetic Research Centre, Bangalore 560 050, India
2Department of Medicine, Cambridge Hospital, Bangalore 560 008, India
3Department of Medicine, Manasa Petal Hospital, Bangalore 560 032, India
4Research and Development Centre, Natural Remedies, Bangalore 560 100, India

Received 25 November 2010; Revised 21 March 2011; Accepted 11 April 2011

Academic Editor: Adair Roberto Soares Santos

Copyright © 2012 Kadur Ramamurthy Raveendra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Holtmann, N. J. Talley, T. Liebregts, B. Adam, and C. Parow, “A placebo-controlled trial of itopride in functional dyspepsia,” The New England Journal of Medicine, vol. 354, no. 8, pp. 832–840, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Adam, T. Liebregts, K. Saadat-Gilani, B. Vinson, and G. Holtmann, “Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia,” Alimentary Pharmacology and Therapeutics, vol. 22, no. 4, pp. 357–363, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Holtmann, B. Adam, S. Haag, W. Collet, E. Grünewald, and T. Windeck, “Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial,” Alimentary Pharmacology and Therapeutics, vol. 18, no. 11-12, pp. 1099–1105, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Qu, H. Q. Gan, Q. B. Mei, and L. Liu, “Study on the effect of Jia-Wei-Xiao-Yao-San decoction on patients with functional dyspepsia,” Phytotherapy Research, vol. 24, no. 2, pp. 245–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Mahadeva and K. L. Goh, “Epidemiology of functional dyspepsia: a global perspective,” World Journal of Gastroenterology, vol. 12, no. 17, pp. 2661–2666, 2006. View at Google Scholar · View at Scopus
  6. A. Haycox, T. Einarson, and A. Eggleston, “The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST),” Scandianavian Journal of Gastroenterology, vol. 34, no. 231, pp. 38–47, 1999. View at Google Scholar · View at Scopus
  7. P. Moayyedi and J. Mason, “Clinical and economic consequences of dyspepsia in the community,” Gut, vol. 50, supplement 4, pp. iv10–iv12, 2002. View at Google Scholar · View at Scopus
  8. L. Chang, “Review article: epidemiology and quality of life in functional gastrointestinal disorders,” Alimentary Pharmacology and Therapeutics, vol. 20, supplement 7, pp. 31–39, 2004. View at Google Scholar · View at Scopus
  9. M. Heikkinen and M. Färkkilä, “What is the long-term outcome of the different subgroups of functional dyspepsia?” Alimentary Pharmacology and Therapeutics, vol. 18, no. 2, pp. 223–229, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Agréus, K. Svärdsudd, N. J. Talley, M. P. Jones, and G. Tibblin, “Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study,” American Journal of Gastroenterology, vol. 96, no. 10, pp. 2905–2914, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Saad and W. D. Chey, “Review article: current and emerging therapies for functional dyspepsia,” Alimentary Pharmacology and Therapeutics, vol. 24, no. 3, pp. 475–492, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. Brook, N. L. Kleinman, R. S. Choung, A. K. Melkonian, J. E. Smeeding, and N. J. Talley, “Functional dyspepsia impacts absenteeism and direct and indirect costs,” Clinical Gastroenterology and Hepatology, vol. 8, no. 6, pp. 498–503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Hikino, “Recent research on oriental medicinal plants,” in Economic and Medicinal Plant Research, H. Wagner, H. Hikino, and N. R. Farnsworth, Eds., pp. 53–85, Academic Press, London, 1985. View at Google Scholar
  14. S. Lata, S. Kakkar, V. K. Srivastava, K. K. Saxena, R. S. Saxena, and A. Kumar, “Comparative antipyretic activity of Ocimum sanctum, Glycyrrhiza glabra and aspirin in experimentally-induced pyrexia in rats,” Indian Journal of Pharmacology, vol. 31, no. 1, pp. 71–75, 1999. View at Google Scholar
  15. N. Wittschier, G. Faller, and A. Hensel, “Aqueous extracts and polysaccharides from Liquorice roots (Glycyrrhiza glabra L.) inhibit adhesion of Helicobacter pylori to human gastric mucosa,” Journal of Ethnopharmacology, vol. 125, no. 2, pp. 218–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Vaya, P. A. Belinky, and M. Aviram, “Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation,” Free Radical Biology and Medicine, vol. 23, no. 2, pp. 302–313, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. J. van Marle, P. N. Aarsen, A. Lind, and J. van Weeren-Kramer, “Deglycyrrhizinised liquorice (DGL) and the renewal of rat stomach epithelium,” European Journal of Pharmacology, vol. 72, no. 2-3, pp. 219–225, 1981. View at Google Scholar · View at Scopus
  18. A. M. Aly, L. Al-Alousi, and H. A. Salem, “Licorice: a possible anti-inflammatory and anti-ulcer drug,” AAPS PharmSciTech, vol. 6, no. 1, article 13, pp. E74–E82, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Fukai, A. Marumo, K. Kaitou, T. Kanda, S. Terada, and T. Nomura, “Anti-Helicobacter pylori flavonoids from licorice extract,” Life Sciences, vol. 71, no. 12, pp. 1449–1463, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. Jafarian and K. Ghazvini, “In vitro susceptibility of Helicobacter pylori to licorice extract,” The Iranian Journal of Pharmaceutical Research, vol. 6, no. 1, pp. 69–72, 2007. View at Google Scholar
  21. A. Bennett, T. Clark-Wibberley, I. F. Stamford, and J. E. Wright, “Aspirin-induced gastric mucosal damage in rats: cimetidine and deglycyrrhizinated liquorice together give greater protection than low doses of either drug alone,” Journal of Pharmacy and Pharmacology, vol. 32, no. 2, p. 151, 1980. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Habibullah, V. Chandra, C. Padmanabham, and R. Datla, “A double blind trial of deglycyrrhizinated liquorice in peptic ulcer,” The Indian Practitioner, vol. 32, no. 2, pp. 119–122, 1979. View at Google Scholar
  23. W. Larkworthy and P. F. L. Holgate, “Deglycyrrhizinized liquorice in the treatment of chronic duodenal ulcer. A retrospective endoscopic survey of 32 patients,” The Practitioner, vol. 215, no. 1290, pp. 787–792, 1975. View at Google Scholar · View at Scopus
  24. M. T. Murray and J. E. Pizzorno Jr., “Glycyrrhiza glabra,” in Textbook of Natural Medicine, M. T. Murray and J. E. Pizzorno Jr., Eds., pp. 767–773, Churchill Livingstone, London, UK, 2nd edition, 1999. View at Google Scholar
  25. C. V. Chandrasekaran, H. B. Deepak, P. Thiyagarajan et al., “Dual inhibitory effect of Glycyrrhiza glabra (GutGard) on COX and LOX products,” Phytomedicine, vol. 18, no. 4, pp. 278–284, 2011. View at Publisher · View at Google Scholar
  26. M. Mukherjee, N. Bhaskaran, R. Srinath et al., “Anti-ulcer and antioxidant activity of GutGard,” Indian Journal of Experimental Biology, vol. 48, no. 3, pp. 269–274, 2010. View at Google Scholar
  27. Rome Foundation, 2006, http://www.romecriteria.org/pdfs/DyspepMode.pdf.
  28. S. J. O. V. van Zanten, N. Chiba, D. Armstrong et al., “Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials,” Alimentary Pharmacology and Therapeutics, vol. 23, no. 4, pp. 521–529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. N. J. Talley, M. Verlinden, and M. Jones, “Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form,” Alimentary Pharmacology and Therapeutics, vol. 15, no. 2, pp. 207–216, 2001. View at Publisher · View at Google Scholar
  30. S. Mahadeva, H. L. Wee, K. L. Goh, and J. Thumboo, “The EQ-5D (Euroqol) is a valid generic instrument for measuring quality of life in patients with dyspepsia,” BMC Gastroenterology, vol. 9, article 20, 2009. View at Publisher · View at Google Scholar
  31. R. B. Dell, S. Holleran, and R. Ramakrishnan, “Sample size determination,” ILAR Journal, vol. 43, no. 4, pp. 207–213, 2002. View at Google Scholar · View at Scopus
  32. J. H. Zar, “More on dichotomous variables,” in Biostatistical Analysis, pp. 516–570, Pearson Education, (Singapore) Pte. Ltd, 2003. View at Google Scholar
  33. J. T. Coon and E. Ernst, “Systematic review: herbal medicinal products for non-ulcer dyspepsia,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 10, pp. 1689–1699, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. K. Gupta, J. Katyal, G. Kumar et al., “Evaluation of antitussive activity of formulations with herbal extracts in sulphur dioxide (SO2) induced cough model in mice,” Indian Journal of Physiology and Pharmacology, vol. 53, no. 1, pp. 61–66, 2009. View at Google Scholar · View at Scopus
  35. A. R. Dehpour, M. E. Zolfaghari, T. Samadian, F. Kobarfard, M. Faizi, and M. Assari, “Antiulcer activities of liquorice and its derivatives in experimental gastric lesion induced by ibuprofen in rats,” International Journal of Pharmaceutics, vol. 119, no. 2, pp. 133–138, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. K. J. Gundermann, E. Godehardt, and M. Ulbrich, “Efficacy of a herbal preparation in patients with functional dyspepsia: a meta-analysis of double-blind, randomized, clinical trials,” Advances in Therapy, vol. 20, no. 1, pp. 43–49, 2003. View at Google Scholar · View at Scopus
  37. J. Melzer, F. Iten, J. Reichling, and R. Saller, “Iberis amara L. and Iberogast—results of a systematic review concerning functional dyspepsia,” Journal of Herbal Pharmacotherapy, vol. 4, no. 4, pp. 51–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. N. J. Talley, V. Stanghellini, R. C. Heading, K. L. Koch, J. R. Malagelada, and G. N. J. Tytgat, “Functional gastroduodenal disorders,” Gut, vol. 45, supplement 2, pp. II37–II42, 1999. View at Google Scholar · View at Scopus
  39. M. Bortolotti, G. Coccia, G. Grossi, and M. Miglioli, “The treatment of functional dyspepsia with red pepper,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 6, pp. 1075–1082, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. F. G. Miller and H. Brody, “What makes placebo-controlled trials unethical?” The American Journal of Bioethics, vol. 2, no. 2, pp. 3–9, 2002. View at Google Scholar · View at Scopus
  41. J. T. F. Lau, J. Mao, and J. Woo, “Ethical issues related to the use of placebo in clinical trials,” Hong Kong Medical Journal, vol. 9, no. 3, pp. 192–198, 2003. View at Google Scholar · View at Scopus
  42. F. Aoki, K. Nakagawa, M. Kitano et al., “Clinical safety of Licorice Flavonoid Oil (LFO) and pharmacokinetics of glabridin in healthy humans,” Journal of the American College of Nutrition, vol. 26, no. 3, pp. 209–218, 2007. View at Google Scholar · View at Scopus
  43. R. A. Isbrucker and G. A. Burdock, “Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin,” Regulatory Toxicology and Pharmacology, vol. 46, no. 3, pp. 167–192, 2006. View at Publisher · View at Google Scholar · View at Scopus